Anti-JCV antibody index does not change during ocrelizumab-treatment [PDF]
Objective To prospectively assess anti-JCV antibody index (AI) and its relationship to immunoglobulin levels in ocrelizumab-treated MS patients. Methods Monocentric prospective observational study over 24 months assessing anti-JCV AI and immunoglobulin ...
Torge Rempe +3 more
doaj +5 more sources
Improved therapeutic index of an acidic pH-selective antibody [PDF]
Although therapeutically efficacious, ipilimumab can exhibit dose-limiting toxicity that prevents maximal efficacious clinical outcomes and can lead to discontinuation of treatment.
Peter S. Lee +17 more
doaj +3 more sources
Therapeutic index improvement of antibody-drug conjugates
The commentary by Colombo and Rich recently published in Cancer Cell provides a timely and comprehensive review of the clinical maximum tolerated doses (MTDs) of antibody−drug conjugates (ADCs) and their corresponding small molecules/chemotherapies.
Hans-Peter Gerber +2 more
doaj +3 more sources
Anti-Cyclic Citrullinated Peptide Antibody Index in the Cerebrospinal Fluid for the Diagnosis and Monitoring of Rheumatoid Meningitis [PDF]
Rheumatoid meningitis (RM) is a rare but often aggressive neurological complication of rheumatoid arthritis. The diagnosis of RM, besides the clinical, radiological, and laboratory criteria, usually requires a cerebral biopsy.
Luigi Caputi +9 more
doaj +2 more sources
Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study. [PDF]
BACKGROUND:Risk of natalizumab-related progressive multifocal leukoencephalopathy is associated with the presence of anti-JC-virus (JCV) antibodies.
Harald Hegen +7 more
doaj +2 more sources
Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis [PDF]
Background: Risk of natalizumab-related progressive multifocal leukoencephalopathy is associated with the presence of anti-JC-virus (JCV) antibodies.Objective: To investigate the impact of disease-modifying treatments (DMT) on the longitudinal evolution ...
Harald Hegen +8 more
doaj +2 more sources
Impact of COVID-19 on Cytomegalovirus Immunoglobulin M Antibody Index
Background: Coronavirus disease 2019 (COVID-19) influenced the prevalence of other infectious diseases, including congenital cytomegalovirus (CMV) infection. However, the effect of COVID-19 on antibody titers has not been reported.
Masatoki Kaneko +4 more
doaj +2 more sources
The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children. [PDF]
For laboratory diagnostics of Lyme neuroborreliosis (LNB), the recomBead Borrelia antibody index (AI) assay has shown promising results in a mixed age population, but has not previously been evaluated with specific focus on paediatric patients. The aim of the study was to evaluate the recomBead Borrelia AI assay in cerebrospinal fluid (CSF) for the ...
Skogman BH +3 more
europepmc +6 more sources
IgG intrathecal synthesis and specific antibody index in patients with neurocysticercosis [PDF]
We analyzed cerebrospinal fluid (CSF) and blood serum from 55 patients with neurocysticercosis (NC) at different clinical stages. According to inflammatory activity in the CSF, three stages were identified: (1) reactive, when there was at least an ...
Luís R. Machado +6 more
doaj +6 more sources
Antibody Index In Neuroimmunoepidemiological Studie
The evaluation of the neuroimmunoepidemiological response from the reibergram allows the determination of the specific antibody index for a determined etiological agent.
Eneida Barrios-Lamoth +1 more
doaj +1 more source

